1.1Crystals with a fumarate counterion
Equimolar amounts of fumaric acid and free base supply the components of a 1:1 salt. The amine accepts one proton, and the hydrogen fumarate anion balances its charge in the crystalline solid.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
Equimolar amounts of fumaric acid and free base supply the components of a 1:1 salt. The amine accepts one proton, and the hydrogen fumarate anion balances its charge in the crystalline solid.
One molar equivalent of methanesulfonic acid protonates the free base to form a 1:1 salt. Addition of a miscible antisolvent reduces salt solubility and promotes crystallization.
The formulation combines two molar parts of free base with one molar part of sulfuric acid. Two singly protonated amine molecules and one sulfate ion form the charge-balanced composition of the solid.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A forensic laboratory uses the spirocyclic amine hydrochloride as a reference material for identifying the amine in extracts. An analyst prepares a stock solution from a weighed portion of the hydrochloride, corrects the concentration for the assayed amine content, and adds an aliquot to a blank matrix before extraction. Liquid chromatography with tandem mass spectrometry compares the retention time and fragment ion ratios of the fortified control with those of the sample.
Methanesulfonic acid replaces hydrochloric acid as the proton donor, and methanesulfonate serves as the counterion. A stirred vessel holds the spirocyclic free base in ethanol while the operator adds methanesulfonic acid at a 1:1 molar feed ratio. The operator adds ethyl acetate to reduce salt solubility, cools the mixture, and filters the resulting solid. Quantitative proton nuclear magnetic resonance measures the methanesulfonate-to-amine molar ratio.
Three jacketed vessels hold equal portions of a filtered, near-saturated solution of the spirocyclic amine hydrochloride at 40 °C. Each vessel receives 0.5% by mass of the same seed lot relative to the dissolved salt and cools to 10 °C at 0.2, 0.5, or 1.0 °C per minute. After a 60-minute hold at 10 °C, the operator filters each slurry and measures the particle size distribution by laser diffraction. Powder X-ray diffraction compares the recovered solids with the seed material.
A spiral jet mill uses dry nitrogen to accelerate spirocyclic amine hydrochloride crystals through a grinding chamber, where particle collisions reduce their size. The operator tests grinding pressures of 3, 5, and 7 bar gauge and collects the discharge in a filter receiver. Laser diffraction measures the particle size distribution for each run against a target median diameter of 10 to 20 µm. Powder X-ray diffraction compares each milled sample with the unmilled feed.
Loss-in-weight feeders meter the spirocyclic amine hydrochloride, microcrystalline cellulose, and croscarmellose sodium into a continuous blender. A downstream feeder introduces magnesium stearate through a short secondary blending stage, and a feed frame transfers the lubricated blend into the dies of a rotary tablet press. The press adjusts die fill using tablet mass measurements, and an offline chromatographic assay measures spirocyclic amine content in sampled tablets.
An immersion Raman probe records spectra from a stirred crystallization vessel containing the spirocyclic amine hydrochloride. Software fits each spectrum against reference spectra from the starting solution and slurry samples whose crystalline phases are identified by powder X-ray diffraction. A controller ends the final temperature hold after the target-phase signal exceeds a threshold set during calibration and stays stable for 10 minutes. The controller then transfers the slurry to a filter, and powder X-ray diffraction verifies the recovered phase.
One molar equivalent of hydrogen chloride protonates the free base in an alcoholic solvent. Hydrochloride seed crystals are added to the supersaturated solution, and controlled cooling grows crystals for collection by filtration.
The free base reacts with hydrogen chloride in a polar solvent to form dissolved protonated amine and chloride ions. A miscible antisolvent is added at constant temperature to reduce hydrochloride solubility and induce crystallization.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
A process for preparing N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)-phenyl]propan-1-amine hydrochloride salt of formula (I) i.e.A · US 2011/0306794 A1 · abstract
The invention relates to a process for preparing the active product ingredient Cinacalcet hydrochloride (CNC.HCl), namely N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride of formula (I)B · US 2014/0296574 A1 · ¶ 1
An empty cell means only that no passage was reproduced there.
The invention relates to a process for preparing the active product ingredient Cinacalcet hydrochloride (CNC.HCl), namely N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride of formula (I)A · US 2011/0306794 A1 · ¶ 1
The invention relates to a process for preparing the active product ingredient Cinacalcet hydrochloride (CNC.HCl), namely N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride of formula (I)B · US 2014/0296574 A1 · ¶ 1
patent.fyi, US 2026/0355151 A1, claim 1, first published 2026-11-19T08:28:42-05:00, https://patent.fyi/US20260355151/, SHA-256 23f76ed0479952487f239e3b075761a6610ecf1874b0b2fd8d08bd3ef0856e99